A combination of intravenous immunoglobulin and pulse methylprednisolone extended survival in pulmonary alveolar proteinosis with chronic interstitial pneumonitis: A case report

Asian Pacific Journal of Allergy and Immunology

Volumn 28, Issue 2-3, 2010, Pages 200-205

  Jirarattanasopa, Nongnapa ^a   Tantikul, Chutsumarn ^a   Vichyanond, Pakit ^a   Pacharn, Punchama ^a   Visitsunthorn, Nualanong ^a   Suttinont, Panthep ^b   Jirapongsananuruk, Orathai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chronic interstitial pneumonitis; Intravenous immunoglobulin; Pulmonary alveolar proteinosis; Pulse methylprednisolone

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; CASE REPORT; CHILD; CONVALESCENCE; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LOW DRUG DOSE; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG LAVAGE; OXYGEN THERAPY; PERINATAL PERIOD; PRESCHOOL CHILD; RESPIRATORY DISTRESS; SURVIVAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

CHRONIC DISEASE; CYANOSIS; DYSPNEA; FATAL OUTCOME; FEMALE; HUMANS; HYPERBARIC OXYGENATION; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INFANT, NEWBORN; LUNG; LUNG DISEASES, INTERSTITIAL; METHYLPREDNISOLONE; PNEUMOCYSTIS JIROVECII; PULMONARY ALVEOLAR PROTEINOSIS; RESPIRATORY INSUFFICIENCY;

EID: 78649517641     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. de Blic J. Pulmonary alveolar proteinosis in children. Pediatr Respir Rev 2004; 5: 316-22.
2. Trapnell BC, Whitsett JA, Nokata K. Pulmonary alveolar proteinosis. N Eng J Med 2003; 349: 2527-39.
3. Frazier AA, Franks TF, Cooke EO, Mohammed TH, Pugatch RD, Galvin JR. Pulmonary alveolar proteinosis. Radio Graphics 2008; 28: 883-99.
4. Ioachimescu OC, Kavuru MS. Pulmonary alveolar proteinosis. Chron Respir Dis 2006; 3: 149-59.
5. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009; 12: 253-74.
6. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004; 350: 1296-303.
7. Doan ML, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008; 63: 366-73.
8. Kitamura T, Tanaka N, Watanabe J et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999; 190: 875-80.
9. Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 2002; 27: 481-6.
10. Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 162: 658-62.
11. Latzin P, Tredano M,Wust Y, et al. Anti-GM-CSF antibodies in pediatric pulmonary alveoloar proteinosis. Thorax 2005; 60: 39-44.
12. Fan LL, Langston C. Interstitial lung disease. In: Chernick V, Boat TF, Wilmott RW, Bush A, eds. Kendig's disorders of the respiratory tract in children. 7th ed., Philadelphia, Saunders Elsevier, 2006; pp. 666-75.
13. Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007; 176: 1120-8.
14. Kavuru MS, Popovich M. Therapeutic whole lung lavage: a stop-gap therapy for alveolar proteinosis. Chest 2002; 122: 1123-4.
15. Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000; 55: 67-77.
16. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166: 215-35.
17. Beccaria M, Luisetti M, Rodi G, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J 2004; 23: 526-31.
18. Paschen C, Reiter K, Stanzel F, Teschler H, Griese M. Therapeutic lung lavages in children and adults. Respiratory Research 2005; 6: 138-47.
19. Seymour JF, Dunn AR, Vincent JM, Presneill JJ, Pain MC. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med 1996; 335: 1924-5.
20. Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 161: 1143-8.
21. Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001; 163: 524-31.
22. Venkateshiah SB, Yan TD, Bonfield TL, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest 2006; 130: 227-37.
23. Wylam ME, Ten R, Prakash UBS, Nadrous HF, Clawson ML, Anderson PM. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J 2006; 27: 585-93.
24. Tazawa R, Hamano E, Arai T, et al. Granulocyte-macrophage colonystimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005; 171: 1142-9.
25. Morgan C. The benefits of whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J 2004; 23: 503-5.
26. Price A, Manson D, Cutz E, Dell S. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF. Pediatr Pulmonol 2006; 41: 367-70.
27. Yamamoto H, Yamaguchi E, Agata H, et al. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Pediatr Pulmonol 2008; 43: 828-30.
28. Doerschuk CM. Pulmonary alveolar proteinosis - Is host defense awry? N Engl J Med 2007; 356: 547-9.
29. Uchida K, Beck DC, Yamamoto T, et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 2007; 356: 567-79.
30. Bayry J, Misra N, Latry V, et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Transfus Clin Biol 2003; 10: 165-9.
31. Cho K, Nakata K, Ariga T, et al. Successful treatment of congenital pulmonary alveolar proteinosis with intravenous immunoglobulin G administration. Respirology 2006; 11: S74-7.
32. Patiroglu T, Akyildiz B, Patiroglu TE, Gulmez IY. Recurrent pulmonary alveolar proteinosis secondary to agammaglobulinemia. Pediatr Pulmonol 2008; 43: 710-3.